SCHEMBL676424

SCHEMBL676424

CCC(=O)C(C)=CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676423 1.00
SCHEMBL15509040 1.00
SCHEMBL17503296 0.97
SCHEMBL17503295 0.97
SCHEMBL811235 0.79
SCHEMBL811234 0.79
SCHEMBL12354183 0.78
SCHEMBL4451614 0.77
SCHEMBL4451616 0.77
SCHEMBL13936167 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108484578-B A kind of method of esomeprazole impurity preparation 珠海润都制药股份有限公司 2019-03-26 CN disclosed
CN-108484578-A A kind of method prepared by esomeprazole impurity 珠海润都制药股份有限公司 2018-09-04 CN disclosed
US-8957056-B2 Migrastatin analogs in the treatment of cancer SLOAN-KETTERING INSTIUTE FOR CANCER RESEARCH (US) 2015-02-17 US disclosed
CN-103044402-B Method for synthesizing esomeprazole sodium KAMP PHARMACEUTICALS CO LTD 2015-01-14 CN disclosed
US-8835693-B2 Migrastatin analogs and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2014-09-16 US disclosed
US-20140011844-A1 MIGRASTATIN ANALOGS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2014-01-09 US disclosed
CN-103044402-A Method for synthesizing esomeprazole sodium KAMP PHARMACEUTICALS CO LTD 2013-04-17 CN disclosed
US-8324284-B2 Migrastatin analogs and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2012-12-04 US disclosed
US-8202911-B2 Migrastatin analog compositions and uses thereof CORNELL RESEARCH FOUNDATION, INC. (US) 2012-06-19 US disclosed
US-20110281916-A1 MIGRASTATIN ANALOGS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2011-11-17 US disclosed
US-20070037852-A1 Migrastatin analogs and uses thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-02-15 US disclosed
EP-1613603-A2 MIGRASTATIN ANALOGS AND USES THEREOF Sloan-Kettering Institute For Cancer Research (US) 2006-01-11 EP disclosed
WO-2006001967-A2 MIGRASTATIN ANALOGS IN THE TREATMENT OF CANCER SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2006-01-05 WO disclosed
EP-1608626-A1 MIGRASTATIN ANALOG COMPOSITIONS AND USES THEREOF CORNELL RESEARCH FOUNDATION, INC. (US) 2005-12-28 EP disclosed
WO-2004087672-A1 MIGRASTATIN ANALOG COMPOSITIONS AND USES THEREOF CORNELL RESEARCH FOUNDATION, INC. (US) 2004-10-14 WO disclosed
WO-2004087673-A2 MIGRASTATIN ANALOGS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2004-10-14 WO disclosed
US-6043371-A Organic compound synthesis BALDWIN JACK EDWARD (GB) 2000-03-28 US disclosed
EP-0899268-A2 Process for the preparation of omeprazole and intermediate compounds Baldwin, Jack Edward (GB) 1999-03-03 EP disclosed
US-5625069-A Process for preparing 2-cyano-3,5-dimethyl-4-methoxypyridine DEVELOPMENT CENTER FOR BIOTECHNOLOGY (CN) 1997-04-29 US disclosed
US-5616713-A Process of preparing 2-hydroxymethyl-3,5-dimethyl-4-methoxypyridine DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) 1997-04-01 US disclosed